Obviousness Of Genomics Company’s Patents Affirmed By Federal Circuit
WASHINGTON, D.C. — Substantial evidence supported the U.S. Patent Trial and Appeal Board’s (PTAB) factual findings that led to it determining that all claims in multiple patents held by a genomics...To view the full article, register now.
Already a subscriber? Click here to view full article